# A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation

> **NCT01283438** · PHASE4 · UNKNOWN · sponsor: **Intrinsic Therapeutics** · enrollment: 554 (actual)

## Conditions studied

- Lumbar Disc Herniation

## Interventions

- **DEVICE:** Barricaid
- **DEVICE:** Standard of Care

## Key facts

- **NCT ID:** NCT01283438
- **Lead sponsor:** Intrinsic Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12-17
- **Primary completion:** 2016-10
- **Final completion:** 2025-06
- **Target enrollment:** 554 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283438, "A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT01283438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*